Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1)

被引:136
作者
Bakos, Eva
Homolya, Laszlo
机构
[1] Hungarian Acad Sci, Membrane Res Grp Membrane Biol & Immunopathol, Natl Med Ctr, H-1113 Budapest, Hungary
[2] Hungarian Acad Sci, Inst Enzymol, H-1113 Budapest, Hungary
来源
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY | 2007年 / 453卷 / 05期
关键词
ABC transporter; xenobiotic transport; multispecific organic anion transporter; multidrug resistance; cancer drug resistance; glutathione conjugates; detoxification;
D O I
10.1007/s00424-006-0160-8
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
MRP1 (ABCC1) is a peculiar member of the ABC transporter superfamily for several aspects. This protein has an unusually broad substrate specificity and is capable of transporting not only a wide variety of neutral hydrophobic compounds, like the MDR1/P-glycoprotein, but also facilitating the extrusion of numerous glutathione, glucuronate, and sulfate conjugates. The transport mechanism of MRP1 is also complex; a composite substrate-binding site permits both cooperativity and competition between various substrates. This versatility and the ubiquitous tissue distribution make this transporter suitable for contributing to various physiological functions, including defense against xenobiotics and endogenous toxic metabolites, leukotriene-mediated inflammatory responses, as well as protection from the toxic effect of oxidative stress. In this paper, we give an overview of the considerable amount of knowledge which has accumulated since the discovery of MRP1 in 1992. We place special emphasis on the structural features essential for function, our recent understanding of the transport mechanism, and the numerous assignments of this transporter.
引用
收藏
页码:621 / 641
页数:21
相关论文
共 192 条
  • [21] Chan HSL, 1997, CANCER RES, V57, P2325
  • [22] N-terminal transmembrane domain of the SUR controls trafficking and gating of Kir6 channel subunits
    Chan, KW
    Zhang, HL
    Logothetis, DE
    [J]. EMBO JOURNAL, 2003, 22 (15) : 3833 - 3843
  • [23] Apparent lack of Mrp1-mediated efflux at the luminal side of mouse blood-brain barrier endothelial cells
    Cisternino, S
    Rousselle, C
    Lorico, A
    Rappa, G
    Scherrmann, JM
    [J]. PHARMACEUTICAL RESEARCH, 2003, 20 (06) : 904 - 909
  • [24] COLE SPC, 1994, CANCER RES, V54, P5902
  • [25] OVEREXPRESSION OF A TRANSPORTER GENE IN A MULTIDRUG-RESISTANT HUMAN LUNG-CANCER CELL-LINE
    COLE, SPC
    BHARDWAJ, G
    GERLACH, JH
    MACKIE, JE
    GRANT, CE
    ALMQUIST, KC
    STEWART, AJ
    KURZ, EU
    DUNCAN, AMV
    DEELEY, RG
    [J]. SCIENCE, 1992, 258 (5088) : 1650 - 1654
  • [26] Sequencing and tissue distribution of the canine MRP2 gene compared with MRP1 and MDR1
    Conrad, S
    Viertelhaus, A
    Orzechowski, A
    Hoogstraate, J
    Gjellan, K
    Schrenk, D
    Kauffmann, HM
    [J]. TOXICOLOGY, 2001, 156 (2-3) : 81 - 91
  • [27] Role for c-jun N-terminal kinase in treatment-refractory acute myeloid leukemia (AML): signaling to multidrug-efflux and hyperproliferation
    Cripe, LD
    Gelfanov, VM
    Smith, EA
    Spigel, DR
    Phillips, CA
    Gabig, TG
    Jung, SH
    Fyffe, J
    Hartman, AD
    Kneebone, P
    Mercola, D
    Burgess, GS
    Boswell, HS
    [J]. LEUKEMIA, 2002, 16 (05) : 799 - 812
  • [28] Functional expression of the multidrug resistance protein 1 in microglia
    Dallas, S
    Zhu, XP
    Baruchel, S
    Schlichter, L
    Bendayan, R
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 307 (01) : 282 - 290
  • [29] Major photoaffinity drug binding sites in multidrug resistance protein 1 (MRP1) are within transmembrane domains 10-11 and 16-17
    Daoud, R
    Julien, M
    Gros, P
    Georges, E
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (15) : 12324 - 12330
  • [30] David-Beabes GL, 2000, INT J ONCOL, V17, P1077